Correlation between Expression of HER-2 and Expression of Receptors of Estrogen and Progestogen in the Breast Cancer and Its Significance
Jiang Yu
Abstract
Jiang Yu
Abstract
Objective:To explore the clinical significance and expression of HER-2,ER and PR in breast cancer tissue.Methods:The expression of HER-2,ER and PR in breast cancer tissues were measured by immunohistochemistry in 167 cases of breast cancers.Results:The positive rates of expression of HER-2,ER and PR in the breast cancers reached 44.9%、53.3% and 49.1%,respectively.The positive rate of expression of HER-2 in the cauces group with the expression of ER,PR was lower than that in the negative group(P0.0 5).The positive rate of expression of HER-2 in the group with the lymph node metastasis was higher than that in non-lymph node metastasis group(P0.05).Conclusion:Measurement of HER-2,ER and PR in the breast cancers played an important role in the prognostic evaluation and guiding of clinical treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the clinical significance and expression of HER-2,ER and PR in breast cancer tissue.Methods:The expression of HER-2,ER and PR in breast cancer tissues were measured by immunohistochemistry in 167 cases of breast cancers.Results:The positive rates of expression of HER-2,ER and PR in the breast cancers reached 44.9%、53.3% and 49.1%,respectively.The positive rate of expression of HER-2 in the cauces group with the expression of ER,PR was lower than that in the negative group(P0.0 5).The positive rate of expression of HER-2 in the group with the lymph node metastasis was higher than that in non-lymph node metastasis group(P0.05).Conclusion:Measurement of HER-2,ER and PR in the breast cancers played an important role in the prognostic evaluation and guiding of clinical treatment.
Key concepts: Medicine, Progestogen, Breast cancer, Immunohistochemistry, Estrogen receptor, Oncology, Internal medicine, Cancer